英国《每日邮报》报道,不少英国肥胖者正在服用的减肥药“诺美亭”眼下正在接受欧洲药品管理局调查,原因是这种药物被怀疑会增大服用者心脏病突发和中风的患病几率。“诺美亭”是西布曲明的商品名,类似成分药物在大多数国家都有销售。这种药物可通过对大脑神经的刺激产生抑制食 Britain’s “Daily Mail” reported that many British obesity is taking the weight-loss drug “normotin” is currently under investigation by the European Medicines Agency, because the drug is suspected of increasing the incidence of heart attack and The risk of stroke. “Nomei Pavilion” is sibutramine’s trade name, similar to the composition of drugs in most countries have sales. This drug can inhibit the brain through nerve stimulation produce food